Planned sale of 3,726 common shares disclosed

John Militello filed a notice of proposed sale of 3,726 shares of common stock of issuer RCKT under Rule 144.

Rhea-AI Filing Summary

John Militello filed a notice of proposed sale of 3,726 shares of common stock of issuer RCKT under Rule 144. The shares, with an aggregate market value of $12,340.88, are to be sold through Fidelity Brokerage Services LLC on NASDAQ, where 108,222,228 shares are outstanding.

The securities were acquired on 02/11/2026 through restricted stock vesting from the issuer as compensation. Militello previously sold 1,086 common shares for gross proceeds of $3,239.32 on 11/18/2025. By signing, he represents he is not aware of undisclosed material adverse information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for RCKT disclose?

The filing discloses that John Militello plans to sell 3,726 RCKT common shares under Rule 144. The shares were recently acquired via restricted stock vesting as compensation and will be sold on NASDAQ through Fidelity Brokerage Services LLC.

How many RCKT shares does John Militello plan to sell under Rule 144?

John Militello plans to sell 3,726 shares of RCKT common stock. These shares have an aggregate market value of $12,340.88 and are to be sold on NASDAQ through Fidelity Brokerage Services LLC, according to the Form 144 notice.

How and when did John Militello acquire the RCKT shares being sold?

The 3,726 RCKT common shares to be sold were acquired on 02/11/2026 through restricted stock vesting. The issuer granted them as compensation, and the date of acquisition and payment are both recorded as February 11, 2026, in the filing.

What prior RCKT share sales has John Militello made recently?

During the past three months, John Militello sold 1,086 RCKT common shares on 11/18/2025. The filing reports gross proceeds of $3,239.32 from this earlier transaction, which must be aggregated with the newly proposed sale for Rule 144 purposes.

How many RCKT shares are outstanding according to the Form 144?

The Form 144 states that 108,222,228 shares of RCKT common stock are outstanding. This figure appears alongside the proposed sale of 3,726 shares and helps contextualize the relative size of the planned Rule 144 transaction.

What representation does the seller make about RCKT’s information in this filing?

By signing the notice, the seller represents that he does not know any material adverse information about RCKT’s current or prospective operations that has not been publicly disclosed, as required by the Rule 144 Form 144 instructions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 03:39 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001662170
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ROCKET PHARMACEUTICALS, INC.
SEC File Number	001-36829
Address of Issuer	350 FIFTH AVENUE SUITE 7530 NEW YORK NEW YORK 10118
Phone	646-440-9100
Name of Person for Whose Account the Securities are To Be Sold	Militello John
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3726	12340.88	108222228	02/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/11/2026	Restricted Stock Vesting	Issuer			3726	02/11/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
John Militello 9 Cedarbrook Drive Cranbury NJ 08512	Common	11/18/2025	1086	3239.32

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	02/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for John Militello
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)